A study published in PLoS Medicine shows “that the new WHO guidelines for early [antiretroviral treatment (ART)] initiation can be cost-effective in resource-poor settings, information that should help policymakers in developing countries allocate their often limited resources,” according to a PLoS press release. Bruce Schackman of Weill Cornell Medical College and…
Programs, Funding & Financing
PlusNews examines how health officials are addressing non-communicable diseases (NCDs) in sub-Saharan Africa, where “[c]ountries grappling with HIV prevalence are now faced with rising epidemics of chronic diseases.”
In this post in the Center for Global Development’s “Global Health Policy” blog, Amanda Glassman, director of global health policy and a research fellow at the center, writes that the “main outcome” of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) is an assignment for the WHO “to lead the…
U.N. Calls For Advancement On Goal To Save Women And Children; Poorest Countries, Drug Company Contribute To Fight
Speaking at a high-level meeting at U.N. headquarters on Tuesday, U.N. Secretary-General Ban Ki-moon, while lauding the progress made under the Every Woman Every Child initiative since its launch one year ago, noted that millions of women and children “are still dying needless deaths and called for advancing the goal of saving 16 million lives by 2015,” the U.N. News Centre reports. A one-year progress update launched at the meeting, Saving the Lives of 16 Million, “shows that in the first year of the effort, commitments have been implemented and enhanced, new partners have come on board, funding has been increased, policies improved and services strengthened on the ground,” according to the news service (9/20).
U.N. Secretary-General Ban Ki-moon on Tuesday is expected “to announce a significant expansion of the organization’s ambitious global program to tackle infant and maternal mortality and boost access to reproductive health over coming years,” the Financial Times reports. The announcement “will highlight the doubling of commitments from governments, the private sector and non-profit organizations on funding and policy initiatives for the ‘Every Woman Every Child’ program,” the newspaper writes (Raval et al., 9/19). The announcement comes “[a]s the U.N. General Assembly opens a new session” and is “being called on [by the international community] to provide more family planning services to hundreds of millions of women,” according to VOA News (DeCapua, 9/19).
Foreign Affairs on Tuesday published an analysis examining the history of negotiations behind the political declaration approved on Monday by leaders attending the U.N. High-level Meeting on Non-Communicable Diseases (NCDs).
Report Warns Against Shifting Funding, Prevention Efforts Away From Countries Successful In Malaria Fight
A new analysis (.pdf) conducted by the African Leaders Malaria Alliance, the Evidence to Policy Initiative at the University of California-San Francisco, and the Clinton Health Access Initiative “warns that if the countries that have produced impressive reductions in malaria cut or stop control activities, malaria will rapidly resurge and a decade of progress will have been in vain,” BMJ News reports.
The Center for Global Health Policy’s “ScienceSpeaks” blog features an interview with Caroline Ryan, director of technical leadership at the Office of U.S. Global AIDS Coordinator (OGAC), where she has worked for seven years. Ryan discusses PEPFAR program implementation, circumcision as an HIV prevention tool and balancing efficiency with the…
Some of the issues to be addressed at the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York “are controversial, including those relating to intellectual property rights for new medicines, diagnostics and medical devices,” James Love, director of Knowledge Ecology International, writes in an Al Jazeera opinion piece. “By continuing to assert that the Doha Declaration is in fact limited in various ways, U.S. and European trade negotiators have tried to discourage the granting of compulsory licenses on patents for high-priced drugs for cancer and other non-communicable diseases,” he continues, before outlining a proposal called the “cancer prize approach” that would de-link drug prices from research and development incentives.
When the results of a large clinical trial testing the effectiveness of the RTS,S malaria vaccine among children in Africa are made available later this year, “it will be time to start discussing what to do with the vaccine,” Orin Levine, executive director of the International Vaccine Access Center at Johns Hopkins University, writes in a Huffington Post opinion piece. “If the vaccine is safe and effective, one of the most important questions will be how to pay for it … and even though Andrew Witty, the CEO of the vaccine’s manufacturer, GSK, has promised to price the vaccine at a point just above its production cost, this price may still end up being too high for many malaria-affected countries to pay for it,” he writes.